‘Left, Right & Center’: The Supreme Court Goes… Phonanimous?
Truthdig Editor-in-Chief Robert Scheer and the other "Left, Right & Center" panelists discuss the Supreme Court's big end-of-term decisions this week, including striking down President Obama's recess appointments, ruling against arrest-related searches of cellphones and putting an end to buffer zones around abortion clinics. Also, the U.S. pledges to help Syrian rebels and Ukraine signs a trade accord.
Truthdig Editor-in-Chief Robert Scheer and the other “Left, Right & Center” panelists discuss the Supreme Court’s big end-of-term decisions this week, including striking down President Obama’s recess appointments, ruling against arrest-related searches of cellphones and putting an end to buffer zones around abortion clinics. Also, the U.S. pledges to help Syrian rebels and Ukraine signs a trade accord.
Scheer is joined by host Matt Miller in the center, Byron York of The Washington Examiner on the right, and Slate.com’s Dahlia Lithwick.
Listen here.
— Adapted from KCRW by Alexander Reed Kelly.
Your support matters…Independent journalism is under threat and overshadowed by heavily funded mainstream media.
You can help level the playing field. Become a member.
Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.
Give today to support our courageous, independent journalists.
Women
Victories show widespread support for abortion protections, even in red states.
Editorial Cartoons
Women
The activist-donor has built a conservative legal movement that works with Republican attorneys general across the country.
Women
From the top of the ticket, the vice president can play a critical role in the fight over reproductive rights.
TD Original
Can a presidential pardon help eliminate the pernicious 1873 law at the heart of the long war against reproductive rights?
Courts & Law
The decision dismisses the case on standing, preserving the 2016 and 2021 expansions to mifepristone access.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.